Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Treatment Strategy for Adolescent Depression (PTAD)
NCT01802437Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2010
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in major depressive disorder (MDD), sponsored by University of Minnesota. Started Nov 2010; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01802437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802437.